Bloomberg Stock Movers

2026-11-16 · Hosted by — · Bloomberg / iHeartMedia

Executive Summary

Bloomberg's Stock Movers opened the week with Nvidia shares still under pressure in pre-market trading following last week's plunge tied to Jensen Huang's ouster. The focus this week shifts to Tuesday's earnings, where interim CEO Collette Kress faces questions, alongside rising government scrutiny after Treasury Secretary Scott Bessent urged Nvidia to find an external CEO candidate and come clean on China export-control compliance.

Key Stories & Changes

1. Nvidia Still Under Pressure Ahead of Tuesday Earnings

  • Shares remain under pressure in pre-market trading following last week's sharp decline tied to Jensen Huang's departure

  • Interim CEO Collette Kress will face questions on Tuesday's earnings call

  • Treasury Secretary Scott Bessent is urging Nvidia toward a "dramatic leadership shake-up," favoring an external CEO candidate

  • Bessent is also pushing Nvidia to clarify its compliance with China export controls and confirm whether adequate security protocols are in place

  • Increasing government scrutiny flagged as the next major headline risk for the stock this week

2. Take-Two Interactive Ahead of GTA 6 Launch

  • TTWO: Take-Two Interactive — Positioned for a strong week — Jefferies: pre-orders tracking above expectations ahead of Thursday's GTA 6 launch

  • Strong pre-order momentum seen supporting a strong 2027 for sales, with a potential PC release boosting 2028 bookings further

3. Crypto-Exposed Stocks Slide With Bitcoin

  • Bitcoin trading below $65,000

  • Galaxy Digital, Circle Internet, and Coinbase all trading sharply lower in pre-market

  • Drivers cited: the aftermath of the massive Binance hack (a "major security crisis" for the sector), political uncertainty since the midterms, rising Treasury yields, and a stronger dollar

  • Traders reportedly bracing for further losses in the sector

4. Summit Therapeutics / Akeso FDA Rejection

  • Summit Therapeutics and Chinese biotech partner Akeso were the biggest pre-market decliners

  • The FDA rejected their lung cancer treatment; while the drug stopped cancer progression, that alone was deemed insufficient for approval

  • Described as a major setback for both companies, with sharp share-price drops

1. Nvidia's Governance Crisis Shifting From Leadership to Policy Scrutiny

The narrative around Nvidia is moving beyond the CEO succession question itself toward direct government pressure on export-control compliance, suggesting the regulatory overhang may persist even after a new CEO is named.

2. Entertainment Spending Resilience Continues Into GTA 6 Launch Week

Strong pre-order tracking for Take-Two reinforces a theme seen elsewhere this week: big, differentiated entertainment franchises are drawing outsized consumer spending even amid broader market uncertainty.

3. Crypto Weakness Compounding Multiple Headwinds Simultaneously

The combination of a major security breach (Binance), macro pressure (higher yields, stronger dollar), and political uncertainty is compounding to produce broad-based weakness across crypto-exposed equities rather than a single isolated catalyst. ---

Sentiment Analysis

Overall Market Sentiment: Cautious

The segment reflects a market still working through Nvidia-specific uncertainty and crypto weakness, with entertainment/gaming names providing a bright spot.

Risk Factors Highlighted

Nvidia regulatory scrutiny: Treasury Secretary Bessent is explicitly pushing for an external CEO and export-control transparency, extending the stock's overhang risk.

Crypto sector security risk: The Binance hack is cited as a "major security crisis" weighing on sentiment across the sector.

Macro headwinds for crypto: Rising Treasury yields and a stronger dollar are compounding pressure on Bitcoin and related equities.

Clinical/regulatory risk in biotech: The Summit Therapeutics/Akeso FDA rejection shows that efficacy alone does not guarantee approval, a risk for similarly positioned drug developers.

This episode was covered in today's [The Market Signal — 2026-11-16](https://marketsignal.beehiiv.com/p/the-market-signal-2026-11-16), a cross-source synthesis of multiple podcast reports.

Keep Reading